Identification of elongation factor g as the conserved cellular target of argyrin B

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Nyfeler, Beat ^a   Hoepfner, Dominic ^b   Palestrant, Deborah ^a   Kirby, Christina A ^a   Whitehead, Lewis ^a   Yu, Robert ^a   Deng, Gejing ^a   Caughlan, Ruth E ^a   Woods, Angela L ^a   Jones, Adriana K ^a   Barnes, S Whitney ^a   Walker, John R ^a   Gaulis, Swann ^b   Hauy, Ervan ^b   Brachmann, Saskia M ^b   Krastel, Philipp ^b   Studer, Christian ^b   Riedl, Ralph ^b   Estoppey, David ^b   Aust, Thomas ^b   Movva, N Rao ^b   Wang, Zuncai ^a   Salcius, Michael ^a   Michaud, Gregory A ^a   McAllister, Gregory ^a   Murphy, Leon O ^a   Tallarico, John A ^a   Wilson, Christopher J ^a   Dean, Charles R ^a   more..

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARGYRIN B PROTEIN; BACTERIAL PROTEIN; ELONGATION FACTOR G; ELONGATION FACTOR G1; UNCLASSIFIED DRUG; ARGYRIN B; MITOCHONDRIAL PROTEIN; MUTANT PROTEIN; OLIGOPEPTIDE;

AMINO ACID SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL STRAIN; BINDING SITE; BURKHOLDERIA MULTIVORANS; CANCER CELL LINE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTALLOGRAPHY; CYTOTOXICITY; DRUG TARGETING; ELECTRON TRANSPORT; FUNGUS GROWTH; GENE SEQUENCE; HUMAN; HUMAN CELL; IC50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; SURFACE PLASMON RESONANCE; ANIMAL; BURKHOLDERIA; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; MAMMAL; METABOLISM; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PSEUDOMONAS AERUGINOSA; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

ALLOSTERIC SITE; AMINO ACID SEQUENCE; ANIMALS; BURKHOLDERIA; CELL LINE, TUMOR; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; HUMANS; MAMMALS; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; OLIGOPEPTIDES; PEPTIDE ELONGATION FACTOR G; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84877109181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042657     Document Type: Article

References (34)

1. Sasse F, Steinmetz H, Schupp T, Petersen F, Memmert K, et al. (2002) Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) 55: 543-551.
2. Selva E, Gastaldo L, Saddler GS, Toppo G, Ferrari P, et al. (1996) Antibiotics A21459 A and B, new inhibitors of bacterial protein synthesis. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) 49: 145-149.
3. Ferrari P, Vekey K, Galimberti M, Gallo GG, Selva E, et al. (1996) Antibiotics A21459 A and B, new inhibitors of bacterial protein synthesis. II. Structure elucidation. J Antibiot (Tokyo) 49: 150-154.
4. Ley SV, Priour A, Heusser C (2002) Total synthesis of the cyclic heptapeptide Argyrin B: a new potent inhibitor of T-cell independent antibody formation. Org Lett 4: 711-714.
5. Vollbrecht L, Steinmetz H, Hofle G, Oberer L, Rihs G, et al. (2002) Argyrins, immunosuppressive cyclic peptides from myxobacteria. II. Structure elucidation and stereochemistry. J Antibiot (Tokyo) 55: 715-721.
6. McConkey DJ (2008) A novel role for a familiar protein in apoptosis induced by proteasome inhibition. Cancer Cell 14: 1-2.
7. Nickeleit I, Zender S, Sasse F, Geffers R, Brandes G, et al. (2008) Argyrin A reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition. Cancer Cell 14: 23-35.
8. Stauch B, Simon B, Basile T, Schneider G, Malek NP, et al. (2010) Elucidation of the structure and intermolecular interactions of a reversible cyclic-peptide inhibitor of the proteasome by NMR spectroscopy and molecular modeling. Angew Chem Int Ed Engl 49: 3934-3938.
9. Bulow L, Nickeleit I, Girbig AK, Brodmann T, Rentsch A, et al. (2010) Synthesis and biological characterization of argyrin F. ChemMedChem 5: 832-836.
10. Rodnina MV, Wintermeyer W (2011) The ribosome as a molecular machine: the mechanism of tRNA-mRNA movement in translocation. Biochem Soc Trans 39: 658-662.
11. Li W, Trabuco LG, Schulten K, Frank J (2011) Molecular dynamics of EF-G during translocation. Proteins 79: 1478-1486.
12. Angus BL, Carey AM, Caron DA, Kropinski AM, Hancock RE (1982) Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother 21: 299-309.
13. Angus BL, Fyfe JA, Hancock RE (1987) Mapping and characterization of two mutations to antibiotic supersusceptibility in Pseudomonas aeruginosa. J Gen Microbiol 133: 2905-2914.
14. Aevarsson A, Brazhnikov E, Garber M, Zheltonosova J, Chirgadze Y, et al. (1994) Three-dimensional structure of the ribosomal translocase: elongation factor G from Thermus thermophilus. EMBO J 13: 3669-3677.
15. Chen Y, Koripella RK, Sanyal S, Selmer M (2010) Staphylococcus aureus elongation factor G-structure and analysis of a target for fusidic acid. FEBS J 277: 3789-3803.
16. Czworkowski J, Wang J, Steitz TA, Moore PB (1994) The crystal structure of elongation factor G complexed with GDP, at 2.7 A resolution. EMBO J 13: 3661-3668.
17. Gao YG, Selmer M, Dunham CM, Weixlbaumer A, Kelley AC, et al. (2009) The structure of the ribosome with elongation factor G trapped in the posttranslocational state. Science 326: 694-699.
18. Smith AM, Ammar R, Nislow C, Giaever G (2010) A survey of yeast genomic assays for drug and target discovery. Pharmacol Ther 127: 156-164.
19. Huh WK, Falvo JV, Gerke LC, Carroll AS, Howson RW, et al. (2003) Global analysis of protein localization in budding yeast. Nature 425: 686-691.
20. Heitman J, Movva NR, Hall MN (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253: 905-909.
21. Smits P, Smeitink J, van den Heuvel L (2010) Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies. J Biomed Biotechnol 2010: 737385.
22. Bodley JW, Zieve FJ, Lin L, Zieve ST (1969) Formation of the ribosome-G factor-GDP complex in the presence of fusidic acid. Biochem Biophys Res Commun 37: 437-443.
23. Tanaka N, Kinoshita T, Masukawa H (1968) Mechanism of protein synthesis inhibition by fusidic acid and related antibiotics. Biochem Biophys Res Commun 30: 278-283.
24. Seo HS, Abedin S, Kamp D, Wilson DN, Nierhaus KH, et al. (2006) EF-Gdependent GTPase on the ribosome. conformational change and fusidic acid inhibition. Biochemistry 45: 2504-2514.
25. Lang BF, Gray MW, Burger G (1999) Mitochondrial genome evolution and the origin of eukaryotes. Annu Rev Genet 33: 351-397.
26. Caughlan RE, Jones AK, Delucia AM, Woods AL, Xie L, et al. (2011) Mechanisms decreasing in vitro susceptibility to the LpxC inhibitor CHIR-090 in the Gram negative pathogen Pseudomonas aeruginosa. Antimicrob Agents Chemother 56:17-27.
27. Kabsch W (2010) Xds. Acta Crystallogr D Biol Crystallogr 66: 125-132.
28. Vonrhein C, Flensburg C, Keller P, Sharff A, Smart O, et al. (2011) Data processing and analysis with the autoPROC toolbox. Acta Crystallogr D Biol Crystallogr 67: 293-302.
29. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674.
30. Hansson S, Singh R, Gudkov AT, Liljas A, Logan DT (2005) Structural insights into fusidic acid resistance and sensitivity in EF-G. J Mol Biol 348: 939-949.
31. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501.
32. Brachmann CB, Davies A, Cost GJ, Caputo E, Li J, et al. (1998) Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast 14: 115-132.
33. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, et al. (2012). The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483(7391);603-607
34. Masuda N, Ohya S (1992) Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 36: 1847-1851.